DHA

Dha is a lipid of Fatty Acyls (FA) class. Dha is associated with abnormalities such as Atherosclerosis, Consumption-archaic term for TB, Chronic disease, Cardiovascular Diseases and Diabetes Mellitus, Non-Insulin-Dependent. The involved functions are known as Inflammation, Oxidation, fatty acid oxidation, Fatty Acid Metabolism and Lipid Metabolism. Dha often locates in Hepatic, Protoplasm, Mucous Membrane, Epithelium and outer membrane. The associated genes with DHA are IMPACT gene, FATE1 gene, GAPDH gene, THOC4 gene and SLC33A1 gene. The related lipids are stearidonic acid, Fatty Acids, Total cholesterol, Lipopolysaccharides and Dietary Fatty Acid. The related experimental models are Mouse Model, Transgenic Model, Animal Disease Models and Arthritis, Experimental.

Cross Reference

Introduction

To understand associated biological information of DHA, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with DHA?

DHA is suspected in Cardiovascular Diseases, Obesity, Ischemia, Hypertensive disease, Coronary Arteriosclerosis, Cerebrovascular accident and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with DHA

MeSH term MeSH ID Detail
Dysbiosis D064806 2 associated lipids
Chronic Pain D059350 5 associated lipids
Peripheral Nerve Injuries D059348 6 associated lipids
Peripheral Arterial Disease D058729 7 associated lipids
Plaque, Atherosclerotic D058226 7 associated lipids
Plaque, Amyloid D058225 19 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Geographic Atrophy D057092 1 associated lipids
Acute Lung Injury D055371 33 associated lipids
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma D054218 5 associated lipids
Acute Coronary Syndrome D054058 11 associated lipids
Hypercalciuria D053565 4 associated lipids
Refsum Disease, Infantile D052919 1 associated lipids
Histiocytoma, Malignant Fibrous D051677 1 associated lipids
Atherosclerosis D050197 85 associated lipids
Dyslipidemias D050171 7 associated lipids
Decapitation D049248 2 associated lipids
Diabetes Complications D048909 4 associated lipids
Premature Birth D047928 6 associated lipids
Malnutrition D044342 6 associated lipids
Metabolic Syndrome D024821 44 associated lipids
Hypoxia-Ischemia, Brain D020925 22 associated lipids
Dyskinesias D020820 3 associated lipids
Spinocerebellar Ataxias D020754 4 associated lipids
Parkinsonian Disorders D020734 20 associated lipids
Multiple Sclerosis, Relapsing-Remitting D020529 7 associated lipids
Stroke D020521 32 associated lipids
Brain Infarction D020520 17 associated lipids
Muscular Dystrophy, Duchenne D020388 11 associated lipids
Intracranial Hemorrhages D020300 2 associated lipids
Neurotoxicity Syndromes D020258 34 associated lipids
Infarction, Middle Cerebral Artery D020244 35 associated lipids
Cerebrovascular Trauma D020214 1 associated lipids
Sleep Apnea, Obstructive D020181 9 associated lipids
Genetic Predisposition to Disease D020022 24 associated lipids
Neurodegenerative Diseases D019636 32 associated lipids
Neuroaxonal Dystrophies D019150 3 associated lipids
Burkholderia Infections D019121 7 associated lipids
Depression, Postpartum D019052 3 associated lipids
Chondrodysplasia Punctata, Rhizomelic D018902 4 associated lipids
Peroxisomal Disorders D018901 5 associated lipids
Carcinoma, Lewis Lung D018827 22 associated lipids
Sepsis D018805 11 associated lipids
Ventricular Dysfunction, Left D018487 33 associated lipids
Pneumonia, Bacterial D018410 16 associated lipids
Trophoblastic Tumor, Placental Site D018245 1 associated lipids
Carcinoma, Embryonal D018236 8 associated lipids
Glucose Intolerance D018149 13 associated lipids
Phenylketonuria, Maternal D017042 1 associated lipids
Keratitis, Herpetic D016849 5 associated lipids
Per page 10 20 50 100 | Total 240

PubChem Associated disorders and diseases

What pathways are associated with DHA

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with DHA?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with DHA?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with DHA?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with DHA?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with DHA?

Mouse Model

Mouse Model are used in the study 'Homeostatic regulation of photoreceptor cell integrity: significance of the potent mediator neuroprotectin D1 biosynthesized from docosahexaenoic acid: the Proctor Lecture.' (Bazan NG, 2007), Mouse Model are used in the study 'Omega-3 fatty acids EPA and DHA: health benefits throughout life.' (Swanson D et al., 2012), Mouse Model are used in the study 'Docosahexaenoic acid attenuates hepatic inflammation, oxidative stress, and fibrosis without decreasing hepatosteatosis in a Ldlr(-/-) mouse model of western diet-induced nonalcoholic steatohepatitis.' (Depner CM et al., 2013) and Mouse Model are used in the study 'Wax esters from the marine copepod Calanus finmarchicus reduce diet-induced obesity and obesity-related metabolic disorders in mice.' (Höper AC et al., 2014).

Transgenic Model

Transgenic Model are used in the study 'Loss of MAP function leads to hippocampal synapse loss and deficits in the Morris Water Maze with aging.' (Ma QL et al., 2014).

Animal Disease Models

Animal Disease Models are used in the study 'Fish oil increases muscle protein mass and modulates Akt/FOXO, TLR4, and NOD signaling in weanling piglets after lipopolysaccharide challenge.' (Liu Y et al., 2013).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with DHA

Download all related citations
Per page 10 20 50 100 | Total 7336
Authors Title Published Journal PubMed Link
Martin CR et al. The safety and efficacy of oral docosahexaenoic acid supplementation for the treatment of primary sclerosing cholangitis - a pilot study. 2012 Aliment. Pharmacol. Ther. pmid:22129201
Ooi SY and Andrews JM Commentary: The association between high dietary intake of docosahexaenoic acid and reduced risk of Crohn's disease. 2014 Aliment. Pharmacol. Ther. pmid:24803245
Chan SS and Hart AR Commentary: The association between high dietary intake of docosahexaenoic acid and reduced risk of Crohn's disease--authors' reply. 2014 Aliment. Pharmacol. Ther. pmid:24803246
Chan SS et al. Association between high dietary intake of the n-3 polyunsaturated fatty acid docosahexaenoic acid and reduced risk of Crohn's disease. 2014 Aliment. Pharmacol. Ther. pmid:24611981
Greenfield SM et al. A randomized controlled study of evening primrose oil and fish oil in ulcerative colitis. 1993 Aliment. Pharmacol. Ther. pmid:8485269
Kankaanpää P et al. Polyunsaturated fatty acids in maternal diet, breast milk, and serum lipid fatty acids of infants in relation to atopy. 2001 Allergy pmid:11421921
Hernández E et al. Prenatal determinants of cord blood total immunoglobulin E levels in Mexican newborns. 2013 Sep-Oct Allergy Asthma Proc pmid:23998234
Arm JP et al. Leukotrienes, fish-oil, and asthma. 1994 May-Jun Allergy Proc pmid:7926711
Logan AC Neurobehavioral aspects of omega-3 fatty acids: possible mechanisms and therapeutic value in major depression. 2003 Altern Med Rev pmid:14653768
Kidd PM Omega-3 DHA and EPA for cognition, behavior, and mood: clinical findings and structural-functional synergies with cell membrane phospholipids. 2007 Altern Med Rev pmid:18072818
Docosahexaenoic acid (DHA). Monograph. 2009 Altern Med Rev pmid:20030466
Yurko-Mauro K et al. Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. 2010 Alzheimers Dement pmid:20434961
Wang X et al. Resolution of inflammation is altered in Alzheimer's disease. 2015 Alzheimers Dement pmid:24530025
Cansev M et al. Oral administration of circulating precursors for membrane phosphatides can promote the synthesis of new brain synapses. 2008 Alzheimers Dement pmid:18631994
Buydens-Branchey L et al. Low plasma levels of docosahexaenoic acid are associated with an increased relapse vulnerability in substance abusers. 2009 Jan-Feb Am J Addict pmid:19219668
New Alzheimer's clinical trials to be undertaken by NIA nationwide consortium. 2006 Dec-2007 Jan Am J Alzheimers Dis Other Demen pmid:17288014
Fialkow J Omega-3 Fatty Acid Formulations in Cardiovascular Disease: Dietary Supplements are Not Substitutes for Prescription Products. 2016 Am J Cardiovasc Drugs pmid:27138439
Fetterman JW and Zdanowicz MM Therapeutic potential of n-3 polyunsaturated fatty acids in disease. 2009 Am J Health Syst Pharm pmid:19535655
Siahanidou T et al. Oxidative stress in preterm infants fed a formula containing long-chain polyunsaturated fatty acids (LCPUFA). 2007 Am J Perinatol pmid:17992715
Cohen JT et al. A quantitative analysis of prenatal intake of n-3 polyunsaturated fatty acids and cognitive development. 2005 Am J Prev Med pmid:16242603
Parker G et al. Omega-3 fatty acids and mood disorders. 2006 Am J Psychiatry pmid:16741195
Nemets H et al. Omega-3 treatment of childhood depression: a controlled, double-blind pilot study. 2006 Am J Psychiatry pmid:16741212
Sublette ME et al. Omega-3 polyunsaturated essential fatty acid status as a predictor of future suicide risk. 2006 Am J Psychiatry pmid:16741213
Marangell LB et al. A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression. 2003 Am J Psychiatry pmid:12727707
Chiu CC et al. Omega-3 fatty acids for depression in pregnancy. 2003 Am J Psychiatry pmid:12562593
Kar S Omacor and omega-3 fatty acids for treatment of coronary artery disease and the pleiotropic effects. 2014 Jan-Feb Am J Ther pmid:21975796
Ryan AS et al. Clinical overview of algal-docosahexaenoic acid: effects on triglyceride levels and other cardiovascular risk factors. 2009 Mar-Apr Am J Ther pmid:19145206
Bucci KK Fish oil supplements. 1992 Am Pharm pmid:1535475
Pratt CM et al. Efficacy and safety of prescription omega-3-acid ethyl esters for the prevention of recurrent symptomatic atrial fibrillation: a prospective study. 2009 Am. Heart J. pmid:19619690
Mehta J et al. Reduction in plasminogen activator inhibitor-1 (PAI-1) with omega-3 polyunsaturated fatty acid (PUFA) intake. 1988 Am. Heart J. pmid:3142242
Zhu BQ et al. Is the reduction of myocardial infarct size by dietary fish oil the result of altered platelet function? 1994 Am. Heart J. pmid:8154411
Haglund O et al. Effects of fish oil on some parameters of fibrinolysis and lipoprotein(a) in healthy subjects. 1994 Am. J. Cardiol. pmid:8023790
Engler MM et al. Effect of docosahexaenoic acid on lipoprotein subclasses in hyperlipidemic children (the EARLY study). 2005 Am. J. Cardiol. pmid:15781019
Bays H Fish oil composition of Omacor and the GISSI trial. 2007 Am. J. Cardiol. pmid:17493490
Barbir M et al. Maxepa versus bezafibrate in hyperlipidemic cardiac transplant recipients. 1992 Am. J. Cardiol. pmid:1466329
Ito MK et al. Omacor effects on serum lipids and clinical outcome. 2007 Am. J. Cardiol. pmid:17196478
Brouwer IA et al. Association between n-3 fatty acid status in blood and electrocardiographic predictors of arrhythmia risk in healthy volunteers. 2002 Am. J. Cardiol. pmid:11867059
Bays H Clinical overview of Omacor: a concentrated formulation of omega-3 polyunsaturated fatty acids. 2006 Am. J. Cardiol. pmid:16919519
Harris WS et al. Effects of omega-3 fatty acids on heart rate in cardiac transplant recipients. 2006 Am. J. Cardiol. pmid:17134636
O'Keefe JH et al. Effects of omega-3 fatty acids on resting heart rate, heart rate recovery after exercise, and heart rate variability in men with healed myocardial infarctions and depressed ejection fractions. 2006 Am. J. Cardiol. pmid:16616012
Silverman DI et al. Usefulness of plasma phospholipid N-3 fatty acid levels in predicting dietary fish intake in patients with coronary artery disease. 1990 Am. J. Cardiol. pmid:2145737
Kim YT et al. Neuroprotection and enhancement of spatial memory by herbal mixture HT008-1 in rat global brain ischemia model. 2008 Am. J. Chin. Med. pmid:18457361
Tolley EA and Carlson SE Considerations of statistical power in infant studies of visual acuity development and docosahexaenoic acid status. 2000 Am. J. Clin. Nutr. pmid:10617938
Metcalf RG et al. Effects of fish-oil supplementation on myocardial fatty acids in humans. 2007 Am. J. Clin. Nutr. pmid:17490956
Griffin MD et al. Effects of altering the ratio of dietary n-6 to n-3 fatty acids on insulin sensitivity, lipoprotein size, and postprandial lipemia in men and postmenopausal women aged 45-70 y: the OPTILIP Study. 2006 Am. J. Clin. Nutr. pmid:17158408
Krauss-Etschmann S et al. Effects of fish-oil and folate supplementation of pregnant women on maternal and fetal plasma concentrations of docosahexaenoic acid and eicosapentaenoic acid: a European randomized multicenter trial. 2007 Am. J. Clin. Nutr. pmid:17490978
Connor WE and Connor SL The importance of fish and docosahexaenoic acid in Alzheimer disease. 2007 Am. J. Clin. Nutr. pmid:17413088
van Gelder BM et al. Fish consumption, n-3 fatty acids, and subsequent 5-y cognitive decline in elderly men: the Zutphen Elderly Study. 2007 Am. J. Clin. Nutr. pmid:17413117
Katoku Y et al. Effect of the cholesterol content of a formula on the lipid compositions of plasma lipoproteins and red blood cell membranes in early infancy. 1996 Am. J. Clin. Nutr. pmid:8942411
Woodman RJ et al. Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension. 2002 Am. J. Clin. Nutr. pmid:12399272
Rosell MS et al. Long-chain n-3 polyunsaturated fatty acids in plasma in British meat-eating, vegetarian, and vegan men. 2005 Am. J. Clin. Nutr. pmid:16087975
Innis SM and Elias SL Intakes of essential n-6 and n-3 polyunsaturated fatty acids among pregnant Canadian women. 2003 Am. J. Clin. Nutr. pmid:12540410
Gillingham LG et al. Dietary oils and FADS1-FADS2 genetic variants modulate [13C]α-linolenic acid metabolism and plasma fatty acid composition. 2013 Am. J. Clin. Nutr. pmid:23221573
West AA et al. Choline intake influences phosphatidylcholine DHA enrichment in nonpregnant women but not in pregnant women in the third trimester. 2013 Am. J. Clin. Nutr. pmid:23446897
Birch EE et al. A randomized controlled trial of long-chain polyunsaturated fatty acid supplementation of formula in term infants after weaning at 6 wk of age. 2002 Am. J. Clin. Nutr. pmid:11864865
Farina EK et al. Protective effects of fish intake and interactive effects of long-chain polyunsaturated fatty acid intakes on hip bone mineral density in older adults: the Framingham Osteoporosis Study. 2011 Am. J. Clin. Nutr. pmid:21367955
de Groot RH et al. Effect of alpha-linolenic acid supplementation during pregnancy on maternal and neonatal polyunsaturated fatty acid status and pregnancy outcome. 2004 Am. J. Clin. Nutr. pmid:14749231
Lemaitre RN et al. n-3 Polyunsaturated fatty acids, fatal ischemic heart disease, and nonfatal myocardial infarction in older adults: the Cardiovascular Health Study. 2003 Am. J. Clin. Nutr. pmid:12540389
Browning LM et al. Incorporation of eicosapentaenoic and docosahexaenoic acids into lipid pools when given as supplements providing doses equivalent to typical intakes of oily fish. 2012 Am. J. Clin. Nutr. pmid:22932281
Harris WS et al. Comparison of the effects of fish and fish-oil capsules on the n 3 fatty acid content of blood cells and plasma phospholipids. 2007 Am. J. Clin. Nutr. pmid:18065578
Muskiet FA et al. The basis of recommendations for docosahexaenoic and arachidonic acids in infant formula: absolute or relative standards? 2007 Am. J. Clin. Nutr. pmid:18065601
Rump P et al. Essential fatty acid composition of plasma phospholipids and birth weight: a study in term neonates. 2001 Am. J. Clin. Nutr. pmid:11273856
Fekete K et al. Methods of assessment of n-3 long-chain polyunsaturated fatty acid status in humans: a systematic review. 2009 Am. J. Clin. Nutr. pmid:19420097
Carlson SE Early determinants of development: a lipid perspective. 2009 Am. J. Clin. Nutr. pmid:19321568
Kestin M et al. n-3 fatty acids of marine origin lower systolic blood pressure and triglycerides but raise LDL cholesterol compared with n-3 and n-6 fatty acids from plants. 1990 Am. J. Clin. Nutr. pmid:1971991
Carlson SE et al. Effect of long-chain n-3 fatty acid supplementation on visual acuity and growth of preterm infants with and without bronchopulmonary dysplasia. 1996 Am. J. Clin. Nutr. pmid:8615350
da Costa KA et al. Docosahexaenoic acid in plasma phosphatidylcholine may be a potential marker for in vivo phosphatidylethanolamine N-methyltransferase activity in humans. 2011 Am. J. Clin. Nutr. pmid:21411618
Wander RC and Du SH Oxidation of plasma proteins is not increased after supplementation with eicosapentaenoic and docosahexaenoic acids. 2000 Am. J. Clin. Nutr. pmid:10966891
Dewailly E E et al. Relations between n-3 fatty acid status and cardiovascular disease risk factors among Quebecers. 2001 Am. J. Clin. Nutr. pmid:11684528
Lin YH et al. Compartmental analyses of 2H5-alpha-linolenic acid and C-U-eicosapentaenoic acid toward synthesis of plasma labeled 22:6n-3 in newborn term infants. 2010 Am. J. Clin. Nutr. pmid:20534748
Decsi T and Boehm G trans Isomeric fatty acids are inversely related to the availability of long-chain PUFAs in the perinatal period. 2013 Am. J. Clin. Nutr. pmid:23824720
Carlson SE et al. Docosahexaenoic acid status of preterm infants at birth and following feeding with human milk or formula. 1986 Am. J. Clin. Nutr. pmid:2947455
Smithers LG et al. Feeding preterm infants milk with a higher dose of docosahexaenoic acid than that used in current practice does not influence language or behavior in early childhood: a follow-up study of a randomized controlled trial. 2010 Am. J. Clin. Nutr. pmid:20053878
Popp-Snijders C and Blonk MC Omega-3 fatty acids in adipose tissue of obese patients with non-insulin-dependent diabetes mellitus reflect long-term dietary intake of eicosapentaenoic and docosahexaenoic acid. 1995 Am. J. Clin. Nutr. pmid:7840075
Stirban A et al. Effects of n-3 fatty acids on macro- and microvascular function in subjects with type 2 diabetes mellitus. 2010 Am. J. Clin. Nutr. pmid:20071644
Thies F et al. Dietary supplementation with eicosapentaenoic acid, but not with other long-chain n-3 or n-6 polyunsaturated fatty acids, decreases natural killer cell activity in healthy subjects aged >55 y. 2001 Am. J. Clin. Nutr. pmid:11237929
Smithers LG et al. Maternal supplementation with docosahexaenoic acid during pregnancy does not affect early visual development in the infant: a randomized controlled trial. 2011 Am. J. Clin. Nutr. pmid:21490140
Giltay EJ et al. Docosahexaenoic acid concentrations are higher in women than in men because of estrogenic effects. 2004 Am. J. Clin. Nutr. pmid:15531662
Otto SJ et al. Comparison of the peripartum and postpartum phospholipid polyunsaturated fatty acid profiles of lactating and nonlactating women. 2001 Am. J. Clin. Nutr. pmid:11382662
van de Rest O et al. Effect of fish-oil supplementation on mental well-being in older subjects: a randomized, double-blind, placebo-controlled trial. 2008 Am. J. Clin. Nutr. pmid:18779287
di Giuseppe R et al. Alcohol consumption and n-3 polyunsaturated fatty acids in healthy men and women from 3 European populations. 2009 Am. J. Clin. Nutr. pmid:19056552
Agostoni C et al. Docosahexaenoic acid supplementation and time at achievement of gross motor milestones in healthy infants: a randomized, prospective, double-blind, placebo-controlled trial. 2009 Am. J. Clin. Nutr. pmid:19056592
Heine-Bröring RC et al. Intake of fish and marine n-3 fatty acids in relation to coronary calcification: the Rotterdam Study. 2010 Am. J. Clin. Nutr. pmid:20219958
Stene LC and Joner G Use of cod liver oil during the first year of life is associated with lower risk of childhood-onset type 1 diabetes: a large, population-based, case-control study. 2003 Am. J. Clin. Nutr. pmid:14668274
Prisco D et al. Effect of n-3 polyunsaturated fatty acid intake on phospholipid fatty acid composition in plasma and erythrocytes. 1996 Am. J. Clin. Nutr. pmid:8644688
Blasbalg TL et al. Changes in consumption of omega-3 and omega-6 fatty acids in the United States during the 20th century. 2011 Am. J. Clin. Nutr. pmid:21367944
Yamazaki K et al. Changes in fatty acid composition in rat blood and organs after infusion of docosahexaenoic acid ethyl ester. 1991 Am. J. Clin. Nutr. pmid:1825741
Marckmann P et al. Biomarkers of habitual fish intake in adipose tissue. 1995 Am. J. Clin. Nutr. pmid:7572741
Francois CA et al. Supplementing lactating women with flaxseed oil does not increase docosahexaenoic acid in their milk. 2003 Am. J. Clin. Nutr. pmid:12499346
van der Merwe LF et al. Long-chain PUFA supplementation in rural African infants: a randomized controlled trial of effects on gut integrity, growth, and cognitive development. 2013 Am. J. Clin. Nutr. pmid:23221579
Lin DS and Conner WE Are the n-3 fatty acids from dietary fish oil deposited in the triglyceride stores of adipose tissue? 1990 Am. J. Clin. Nutr. pmid:2138861
Christensen MS et al. Intestinal absorption and lymphatic transport of eicosapentaenoic (EPA), docosahexaenoic (DHA), and decanoic acids: dependence on intramolecular triacylglycerol structure. 1995 Am. J. Clin. Nutr. pmid:7825539
Subbaiah PV et al. Incorporation of dietary n-3 fatty acids into molecular species of phosphatidyl choline and cholesteryl ester in normal human plasma. 1993 Am. J. Clin. Nutr. pmid:8237847
Geelen A et al. Effects of n-3 fatty acids from fish on premature ventricular complexes and heart rate in humans. 2005 Am. J. Clin. Nutr. pmid:15699229
Mantzioris E et al. Biochemical effects of a diet containing foods enriched with n-3 fatty acids. 2000 Am. J. Clin. Nutr. pmid:10871559
Niu K et al. Dietary long-chain n-3 fatty acids of marine origin and serum C-reactive protein concentrations are associated in a population with a diet rich in marine products. 2006 Am. J. Clin. Nutr. pmid:16825699
Elias SL and Innis SM Infant plasma trans, n-6, and n-3 fatty acids and conjugated linoleic acids are related to maternal plasma fatty acids, length of gestation, and birth weight and length. 2001 Am. J. Clin. Nutr. pmid:11273857
Zhou SJ et al. Fish-oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. 2012 Am. J. Clin. Nutr. pmid:22552037
Harris WS n-3 fatty acids and serum lipoproteins: human studies. 1997 Am. J. Clin. Nutr. pmid:9129504
Innis SM et al. n-6 Docosapentaenoic acid is not a predictor of low docosahexaenoic acid status in Canadian preschool children. 2004 Am. J. Clin. Nutr. pmid:15321820